Clinical Trials
3 trialsNCT04212702 2021-01-12
ESR1 Mutations in Asian ER+ Metastatic Breast Cancer on Hormonal Therapy-based Treatments
National Taiwan University Hospital
Unknown
NCT02809404 2017-10-16
SPOT
Radboud University Medical Center
Completed
NCT02023359 2015-12-29
Danish Observational Study of Everolimus Plus Exemestane in Hormone Receptor (HR) Positive, Human Epidermal Growth Factor 2 (HER2) - Metastatic Breast Cancer
Novartis
Completed